High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.
Daneels W, Van Parys A, Huyghe L, Rogge E, De Rouck S, Christiaen R, Zabeau L, Taveirne S, Van Dorpe J, Kley N, Cauwels A, Depla E, Tavernier J, Offner F.
Daneels W, et al. Among authors: de rouck s.
Exp Hematol Oncol. 2024 Jun 3;13(1):59. doi: 10.1186/s40164-024-00524-4.
Exp Hematol Oncol. 2024.
PMID: 38831452
Free PMC article.